Search Results for “” – Page 3

Arya – Electronic Medical Record Offering for CRA Members

As described by the founder, Arya is a modern, physician-designed electronic medical record (EMR) system built in Canada. It combines everything clinics need—charting, billing, secure messaging, lab integration, online booking, and more—in one intuitive platform. Arya Health is offering CRA […]

Apr 06, 2026

AI Scribes for CRA members

General Information FAQs Learn more about the pilot project: “Getting this to work for you takes some configuration but with rheumatology-focused templates, we have tried to make this process as simple as possible. I think everyone can benefit from the […]

Apr 06, 2026

Annual Awards

Nominate a Member CRA Awards of Distinction CRA Master Awards Practice Reflection Award Abstract Awards The abstract submission system opens on September 14, 2026. Applicants must apply for abstract awards during the abstract submission process to be considered. The Abstract Awards […]

Apr 06, 2026

CRA Memberships

Please consider the membership dues levels, rules and restrictions prior to commencing the application process to ensure your eligibility. Please note: if you are currently employed by the pharmaceutical industry (other than as a contract Research Investigator) as a major part […]

Apr 06, 2026

Canadian Rheumatology Association Position Statement on Criteria for Access to Targeted Agents for Rheumatoid Arthritis in Canada

There are currently significant discrepancies between Canadian provinces and territories in the criteria for access to advanced targeted agents for rheumatoid arthritis (RA) treatment. Such targeted agents include biologic medications as well as small molecule inhibitors. In hopes of supporting […]

Mar 30, 2026

Canadian Rheumatology Association Position Statement on Hydroxychloroquine Monitoring Guidance for Optical Coherence Tomography

The antimalarial drugs, hydroxychloroquine (HCQ) and rarely chloroquine, are essential drugs in the treatment of rheumatic diseases. HCQ is currently the only anti-malarial drug available in Canada for the treatment of rheumatic diseases...

Dec 01, 2025

CRA Position Statement on Quebec’s Bill 2 : Protecting Rheumatology Care and Physician Well-being

The Canadian Rheumatology Association (CRA) strongly opposes Bill 2, recently enacted by the Government of Quebec. This legislation introduces coercive measures that undermine physicians’ rights, destabilize the health care system, and threaten the quality of care for patients living with […]

Nov 05, 2025

CRA/CanRIO guidelines for the management of baseline immunosuppression in individuals with pre-existing rheumatic diseases initiating immune checkpoint inhibitors

This living guideline offers up-to-date guidance on the management of baseline immunosuppression (IS) for pre-existing rheumatic diseases (PRDs) when initiating cancer immunotherapy with immune checkpoint inhibitors (ICIs). Split into 2 parts, this guideline provides contemporary baseline IS recommendations for individuals […]

Sep 01, 2025

Abstracts Presented in 2025

Abstracts Presented at the CRA Annual Scientific Meeting in Calgary, Alberta, February 26-March 1, 2025

Jul 24, 2025

Canadian Rheumatology Association Guidelines Handbook

This document is a guide to developing documents containing clinical guidance for the Canadian Rheumatology Association (CRA). It outlines the procedures required to receive CRA endorsement and the recommended overall approach for development. It is not meant to be a […]

Jun 23, 2025